Effect of a Patient Support Program for Idiopathic Pulmonary Fibrosis Patients on Medication Persistence: A Retrospective Database Analysis.
Aimee M NearChakkarin BurudpakdeeShilpa ViswanathanShuchita KailaPublished in: Advances in therapy (2021)
Real-world evidence suggests a persistence benefit for patients with IPF treated with nintedanib who are enrolled in the patient support program.